Bionano Genomics, Inc. (BNGO) stock
BNGONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 12/3083% below fair value
$0.98+0.02 (+2.50%)
Close on Nov 18, 2026Market cap $11.49MP/E –Yield –
Bionano Genomics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Bionano Genomics's operating cash flow for the twelve months ending Jun 30, 2026 was -$20.48M. For fiscal 2025 it was -$16.35M. The highest annual figure on record is -$16.35M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$16.35M | – |
| FY2024 | Dec 31, 2024 | -$68.92M | – |
| FY2023 | Dec 31, 2023 | -$125.18M | – |
| FY2022 | Dec 31, 2022 | -$124.82M | – |
| FY2021 | Dec 31, 2021 | -$71.93M | – |
| FY2020 | Dec 31, 2020 | -$38.31M | – |
| FY2019 | Dec 31, 2019 | -$29.53M | – |
| FY2018 | Dec 31, 2018 | -$19.94M | – |
| FY2017 | Dec 31, 2017 | -$20.82M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$4.67M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.72M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.18M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.92M | – |
| Q2 FY2025 | Jun 30, 2025 | -$3.49M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.76M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.50M | – |
| Q3 FY2024 | Sep 30, 2024 | -$13.31M | – |
| Q2 FY2024 | Jun 30, 2024 | -$20.98M | – |
| Q1 FY2024 | Mar 31, 2024 | -$28.13M | – |
| Q4 FY2023 | Dec 31, 2023 | -$29.78M | – |
| Q3 FY2023 | Sep 30, 2023 | -$26.29M | – |
| Q2 FY2023 | Jun 30, 2023 | -$36.70M | – |
| Q1 FY2023 | Mar 31, 2023 | -$32.41M | – |
| Q4 FY2022 | Dec 31, 2022 | -$34.52M | – |
| Q3 FY2022 | Sep 30, 2022 | -$29.47M | – |
| Q2 FY2022 | Jun 30, 2022 | -$28.33M | – |
| Q1 FY2022 | Mar 31, 2022 | -$32.49M | – |
| Q4 FY2021 | Dec 31, 2021 | -$25.62M | – |
| Q3 FY2021 | Sep 30, 2021 | -$19.98M | – |
| Q2 FY2021 | Jun 30, 2021 | -$12.42M | – |
| Q1 FY2021 | Mar 31, 2021 | -$13.90M | – |
| Q4 FY2020 | Dec 31, 2020 | -$12.10M | – |
| Q3 FY2020 | Sep 30, 2020 | -$10.96M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.22M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.03M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.38M | – |
| Q3 FY2019 | Sep 30, 2019 | -$7.28M | – |
| Q2 FY2019 | Jun 30, 2019 | -$6.32M | – |
| Q1 FY2019 | Mar 31, 2019 | -$6.55M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.09M | – |
| Q3 FY2018 | Sep 30, 2018 | -$6.10M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.97M | – |
| Q1 FY2018 | Mar 31, 2018 | -$6.79M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.81M | – |
See a number that looks wrong?